Conglomerate-owned

L’Oréal bought Kiehl’s in 2000, not 1988. Who imports it, who sells it in India now, and what it costs against the American price.

SK-II reached India on 1 April 2026 with LUXASIA. P&G owns it, the hero essence works out at ₹89.13 a millilitre, and its “over 90% Pitera” claim is the first on this site the ingredient list supports.

Shiseido reaches India through Baccarose, not through its own Indian entity — and at 90% to 113% of Japanese prices, it costs about what it costs in Tokyo.

The Man Company has nine advertising outcomes against it since 2023, all about product claims. Emami owns it outright and publishes no revenue for it; the register shows a ₹32.54 crore loss.

Ustraa promises beard hair 40% faster with no test published. It has the cheapest beard oil of the big three, and the only falling revenue — ₹96.8 crore to ₹73 crore in two years.

Founded in 1996, owned by LVMH, then Falic, then Castanea, and by L’Oréal since 2012 — at a price neither party ever disclosed. What Urban Decay costs in India, and where the premium sits.

Kering owns the Yves Saint Laurent name; L’Oréal bought the beauty business in 2008 and runs it under licence. What that split means for Indian prices, importers and shade counts.

NYX returned to India in November 2025 as a Nykaa exclusive. Its Indian prices run at 86–105% of the brand’s own US list, against sibling Maybelline’s 52–60%.

Marico took Just Herbs to 100% in September 2024 and absorbed the business a year later. What the packs, the prices and the advertising record actually say.

Puig of Barcelona has controlled Kama Ayurveda since September 2022. What the state register says about its manufacturing licence, and what its serums and sunscreen actually cost per millilitre.

CeraVe’s Indian jars declare Chakan, Pune and licence M MH/105568. The Moisturising Cream’s ingredient list matches the American one exactly — and costs ₹4.62 a gram against ₹3.36 on a US shelf.

Eucerin launched in India in October 2024 at ₹36 to ₹126 a millilitre. Its headline active has a published randomised trial behind it; its advertising carries two upheld ASCI findings.

The Ordinary’s hero serum costs ₹600 in India and $6.00 in America. Estée Lauder paid about $1.7 billion for the brand, and the percentage on the front of the bottle is not in the ingredient list.